BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33459904)

  • 1. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
    Rahman Z; Dharani S; Khuroo T; Khan MA
    AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation Of A Discriminatory Dissolution Method for Portioned Moist Snuff and Snus.
    Rahman Z; Mohamed EM; Dharani S; Khuroo T; Young M; Feng C; Cecil T; Khan MA
    J Pharm Sci; 2022 Jun; 111(6):1700-1708. PubMed ID: 34861248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
    Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study of nicotine release from smokeless tobacco.
    Nasr MM; Reepmeyer JC; Tang Y
    J AOAC Int; 1998; 81(3):540-3. PubMed ID: 9606918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
    Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
    Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
    Lunell E; Fagerström K; Hughes J; Pendrill R
    Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
    Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
    J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
    Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
    Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
    Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
    Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smokeless Tobacco Products (STPs) Harbour Bacterial Populations with Potential for Oral Carcinogenicity.
    Monika S; Dineshkumar T; Priyadharini S; Niveditha T; Sk P; Rajkumar K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):815-824. PubMed ID: 32212812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff.
    Li P; Zhang J; Sun SH; Xie JP; Zong YL
    Chem Cent J; 2013 Nov; 7(1):176. PubMed ID: 24215662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The composition of contemporary American and Swedish smokeless tobacco products.
    McAdam KG; Kimpton H; Faizi A; Porter A; Rodu B
    BMC Chem; 2019 Dec; 13(1):31. PubMed ID: 31384779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Toxicity of Smokeless Tobacco Products in Mice.
    Malovichko MV; Zeller I; Krivokhizhina TV; Xie Z; Lorkiewicz P; Agarwal A; Wickramasinghe N; Sithu SD; Shah J; O'Toole T; Rai SN; Bhatnagar A; Conklin DJ; Srivastava S
    Nicotine Tob Res; 2019 Jan; 21(1):101-110. PubMed ID: 30085294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the brotherhood: Skoal Bandits' role in the evolution of marketing moist smokeless tobacco pouches.
    Hendlin YH; Veffer JR; Lewis MJ; Ling PM
    Tob Induc Dis; 2017; 15():46. PubMed ID: 29270101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products.
    Stanfill S; Tran H; Tyx R; Fernandez C; Zhu W; Marynak K; King B; Valentín-Blasini L; Blount BC; Watson C
    Nicotine Tob Res; 2021 Aug; 23(9):1590-1596. PubMed ID: 34233354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
    Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
    Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Use Topography and Nicotine Pharmacokinetics Among Loose and Portioned Smokeless Tobacco Users.
    Nighbor T; Meredith S; Salazar E; Cartagena C; Koszowski B; Pickworth WB; Hull LC
    Nicotine Tob Res; 2023 Mar; 25(4):624-630. PubMed ID: 35965261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.